Literature DB >> 773823

Inhibitory action of D-galactose on phagocyte metabolism and function.

W J Litchfield, W W Wells.   

Abstract

To account for enhanced susceptibility to infection among galactosemics, the acute effects of D-galactose on metabolic and functional activities of phagocytic cells in vitro were investigated. Human and guinea pig polymorphonuclear leukocytes (PMN) when incubated in medium containing 30 mM galactose displayed substantially less killing of Escherichia coli than when incubated in medium with 5 mM glucose. Impaired bactericidal activity was dependent upon galactose concentration but could be partially averted by supplementing the galactose-containing medium with 15 mM glucose. Phagocytic activities of guinea pig PMN and peritoneal macrophages were assayed by following ingestion of 32P-labeled E. coli and were also depressed by elevated galactose. Galactose was readily epimerized to glucose by resting PMN, and this conversion was stimulated by phagocytosis. Incubation of macrophages in the presence of galactose resulted in depletion of intracellular levels of adenosine 5' -triphosphate as well as other metabolities.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 773823      PMCID: PMC420670          DOI: 10.1128/iai.13.3.728-734.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes.

Authors:  A J SBARRA; M L KARNOVSKY
Journal:  J Biol Chem       Date:  1959-06       Impact factor: 5.157

2.  Studies of erythrocyte phosphate ester metabolism in galactosaemia.

Authors:  J S PENINGTON; T A PRANKERD
Journal:  Clin Sci       Date:  1958-08       Impact factor: 6.124

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Role of sugars in human neutrophilic phagocytosis.

Authors:  A Sanchez; J L Reeser; H S Lau; P Y Yahiku; R E Willard; P J McMillan; S Y Cho; A R Magie; U D Register
Journal:  Am J Clin Nutr       Date:  1973-11       Impact factor: 7.045

5.  Incidence of galactosemia at birth in New York State.

Authors:  S Kelly; J Burns; L Desjardins
Journal:  Am J Epidemiol       Date:  1974-01       Impact factor: 4.897

6.  Galactosemia: early structural changes in the liver.

Authors:  A Medline; N M Medline
Journal:  Can Med Assoc J       Date:  1972-11-04       Impact factor: 8.262

7.  Galactitol in the tissues of a galactosemic child.

Authors:  R Quan-Ma; H J Wells; W W Wells; F E Sherman; T J Egan
Journal:  Am J Dis Child       Date:  1966-11

8.  Effect of osmolarity on phagocytosis.

Authors:  A J SBARRA; W SHIRLEY; J S BAUMSTARK
Journal:  J Bacteriol       Date:  1963-02       Impact factor: 3.490

9.  Galactose-1-phosphate uridyltransferase and galactokinase activity in cultured human diploid fibroblasts and peripheral blood leukocytes. I. Analysis of transferase genotypes by the ratio of the activities of the two enzymes.

Authors:  T A Tedesco; W J Mellman
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

10.  Studies on the effect of experimental nonketotic diabetes mellitus on antibacterial defense. I. Demonstration of a defect in phagocytosis.

Authors:  R H Drachman; R K Root; W B Wood
Journal:  J Exp Med       Date:  1966-08-01       Impact factor: 14.307

View more
  3 in total

1.  Selectivity of the 2-deoxyglucose transport system in human and guinea pig polymorphonuclear leukocytes.

Authors:  W J Litchfield; W W Wells
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

2.  Inhibitory action of galactose on phagocytes from normal and hypergalactosemic chicks.

Authors:  W J Litchfield; W W Wells
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

Review 3.  Phagocytosis. Clinical disorders of recognition and ingestion.

Authors:  T P Stossel
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.